` Comparison: BT3 vs GILD - Alpha Spread

L
BT3
vs
GILD

Over the past 12 months, BT3 has significantly outperformed GILD, delivering a return of +95% compared to the GILD's +48% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BT3
GILD
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BT3 Intrinsic Value
HIDDEN
Show
GILD Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
L
Lineage Cell Therapeutics Inc
F:BT3
1.21 EUR
Gilead Sciences Inc
NASDAQ:GILD
144.76 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BT3, GILD

BT3
GILD
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
L
Lineage Cell Therapeutics Inc
Revenue
Gilead Sciences Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BT3, GILD

BT3
GILD
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
L
Lineage Cell Therapeutics Inc
F:BT3
Gilead Sciences Inc
NASDAQ:GILD
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BT3
97.6%
GILD
78.7%

Operating Margin

BT3
-186.9%
GILD
39%

Net Margin

BT3
-374.8%
GILD
27.9%

FCF Margin

BT3
-212.1%
GILD
33.2%

ROE

BT3
-70.1%
GILD
40.6%

ROA

BT3
-42.3%
GILD
14.3%

ROIC

BT3
-37.4%
GILD
19%

ROCE

BT3
-24.3%
GILD
25.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BT3, GILD

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BT3, GILD

Performance Gap Between BT3 and GILD
HIDDEN
Show

Performance By Year
BT3, GILD

Loading
BT3
GILD
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BT3 to other stocks
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account